Search research articles
Contact Us
Filters
Showing results (281-290 of 345) with videos related to
Page
of 35
Sort By:
RMD Open
|
February 28, 2023
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
Benedicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, et al.
Annals of the Rheumatic Diseases
|
December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.
Arthritis and Rheumatism
|
June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
Johan Askling, C Michael Fored, Lena Brandt, et al.
RMD Open
|
December 23, 2022
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
Rene Lindholm Cordtz, Johan Askling, Benedicte Delcoigne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 5, 2008
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
Annika Bergquist, Scott M Montgomery, Shahram Bahmanyar, et al.
Rheumatology (Oxford, England)
|
October 18, 2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Helga Westerlind, Alf Kastbom, Johan Rönnelid, et al.
RMD Open
|
December 9, 2021
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, et al.
Arthritis and Rheumatism
|
October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases
|
February 24, 2021
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, et al.
Annals of Neurology
|
February 15, 2020
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Peter Alping, Johan Askling, Joachim Burman, et al.
Page
of 35
Search research articles
Search
Showing results (281-290 of 345) with videos related to
Sort By:
Page
of 35
RMD Open
|
February 28, 2023
Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers
Benedicte Delcoigne, Tine Iskov Kopp, Elizabeth V Arkema, et al.
Annals of the Rheumatic Diseases
|
December 5, 2023
In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation
Eleftheria Pertsinidou, Saedis Saevarsdottir, Vivek Anand Manivel, et al.
Arthritis and Rheumatism
|
June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
Johan Askling, C Michael Fored, Lena Brandt, et al.
RMD Open
|
December 23, 2022
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
Rene Lindholm Cordtz, Johan Askling, Benedicte Delcoigne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 5, 2008
Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis
Annika Bergquist, Scott M Montgomery, Shahram Bahmanyar, et al.
Rheumatology (Oxford, England)
|
October 18, 2022
The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis
Helga Westerlind, Alf Kastbom, Johan Rönnelid, et al.
RMD Open
|
December 9, 2021
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
Hannah Bower, Thomas Frisell, Daniela di Giuseppe, et al.
Arthritis and Rheumatism
|
October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?
Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases
|
February 24, 2021
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, et al.
Annals of Neurology
|
February 15, 2020
Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients
Peter Alping, Johan Askling, Joachim Burman, et al.
Page
of 35